G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
The LRRK2 mutation is a major causal mutation in familial Parkinson’s disease. Although LRRK2 contains functional GTPase and kinase domains and their activities are altered by pathogenic mutations, most studies focused on LRRK2 kinase activity because the most prevalent mutant, G2019S, enhances kina...
Main Authors: | Dong Hwan Ho, Jihoon Jang, Eun-hye Joe, Ilhong Son, Hyemyung Seo, Wongi Seol |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/7917128 |
Similar Items
-
G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
by: Dong Hwan Ho, et al.
Published: (2019-03-01) -
Effect of leucine-rich repeat kinase 2 (LRRK2) on protein synthesis
by: Hyejung Kim, et al.
Published: (2018-01-01) -
Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity
by: Jihoon Jang, et al.
Published: (2018-09-01) -
Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants
by: Jing Yang, et al.
Published: (2021-03-01) -
Increased DJ-1 in Urine Exosome of Korean Males with Parkinson’s Disease
by: Dong Hwan Ho, et al.
Published: (2014-01-01)